Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043529
Filing Date
2025-05-15
Accepted
2025-05-14 19:09:47
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241662-10q_klotho.htm   iXBRL 10-Q 517784
2 CERTIFICATION ea024166201ex31-1_klotho.htm EX-31.1 9349
3 CERTIFICATION ea024166201ex31-2_klotho.htm EX-31.2 9704
4 CERTIFICATION ea024166201ex32-1_klotho.htm EX-32.1 4286
5 CERTIFICATION ea024166201ex32-2_klotho.htm EX-32.2 3807
  Complete submission text file 0001213900-25-043529.txt   4458928

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE klto-20250331.xsd EX-101.SCH 44410
7 XBRL CALCULATION FILE klto-20250331_cal.xml EX-101.CAL 27549
8 XBRL DEFINITION FILE klto-20250331_def.xml EX-101.DEF 228273
9 XBRL LABEL FILE klto-20250331_lab.xml EX-101.LAB 379668
10 XBRL PRESENTATION FILE klto-20250331_pre.xml EX-101.PRE 235533
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0241662-10q_klotho_htm.xml XML 398849
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41340 | Film No.: 25947761
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)